Phlo Corporation Commences Shipments to Fill Backlog

Projects Profitable Fiscal Year 2001



Apr 10, 2001, 01:00 ET from Phlo Corporation

    NEW YORK, April 10 /PRNewswire/ -- Phlo Corporation
 (OTC Bulletin Board:   PHLC) ("Phlo") announced today that it has begun shipping
 approximately 200,000 cases of Phlo's flagship ZO - Vital Cell Defense and
 McCoy's beverage products from its co-packing facility in Carteret, New Jersey
 to satisfy a current backlog of approximately $1.8 million.  This backlog
 consists of purchase orders from Phlo's major distributors such as the
 Coca-Cola Bottling Company of Chicago, Inc. (including its affiliates), Haddon
 House, and Atlantic Beverages.  Phlo plans to produce another 200,000 cases of
 its beverages at the end of April to fill orders from its distributors for the
 following 30 day period.
     "This is a pivotal time in the Company's development as we believe that
 the filling of such orders and the meeting of the demand from our existing
 distributors for the ensuing 12 months should allow the Company to be
 profitable for every quarter during the next 12 month period and to show a
 material profit for our fiscal year 2001," James B. Hovis, President and CEO
 of Phlo, said today.  "The Company's operating results for its first fiscal
 quarter of 2001 should generate a substantial balance sheet capable of
 supporting traditional asset-based lending for production financing in the
 future."
     Phlo's ZO - Vital Cell Defense beverages contain Phlo's patent-pending
 payload, Vitamin E phosphate/phosphatidylcholine, which is protected through
 the stomach (micro-encapsulated) and time-released.  This technology has been
 shown through in vitro and in vivo tests to be effective in protecting cells
 from the effects of aging and exposure to toxins.  Further, the patent-pending
 payload has been shown to be effective in stimulating the membrane repair
 function of cells, particularly of the liver, heart, and brain.
     Phlo's distributors currently sell to an account base of approximately
 100,000 accounts, encompassing territories including eastern New York, New
 Jersey, Pennsylvania, Delaware, Maryland, Virginia, North Carolina, South
 Carolina, and Florida, and reaching westward to Illinois, Indiana, Wisconsin,
 Ohio, western Pennsylvania, and western New York (including the major
 metropolitan areas of Chicago, IL, Milwaukee, WI, Indianapolis, IN, and
 Rochester, NY).
 
     Phlo is a manufacturer of beverages containing patented and patent-pending
 biotechnologies.  Phlo's ZO - Vital Cell Defense line of beverages is
 available in ten flavors including Orange Carrot, Cranberry Berry, Tropical
 Punch, Pink Lemonade, Kiwi Strawberry, Raspberry Vanilla, Blackberry Cherry,
 Lemon Iced Tea, Peach Iced Tea, and Raspberry Iced Tea.  Phlo's McCoy's Green
 Tea beverage line, available in five different flavors, is the first and only
 new age beverage that delivers a truly functional level (250 mg) of powerful
 green tea catechins, including the super anti-oxidant EGCg.  Studies show that
 a high daily intake of EGCg aids in the protection against cancer and
 cardiovascular disease.  McCoy's Green Teas also feature Vitamin C and
 Siberian ginseng for sustained energy and concentration.  Phlo is based in New
 York City at 475 Park Avenue South, Seventh Floor, New York, New York 10016.
 For more information, contact Michael J. Sclafani, Wall Street Communications
 Group, Inc., 303-541-0970, sclafani@uswest.net.
 
     Certain statements made herein constitute "forward-looking" statements
 within the meaning of the Private Litigation Reform Act of 1995.  Such
 statements are based on a number of assumptions and on information and
 estimates supplied to Phlo Corporation by its distributors.  Such assumptions
 and estimates are subject to uncertainties, contingencies, and other factors,
 many of which are beyond Phlo's control.  Actual results may differ materially
 from the statements set forth above.
 
 

SOURCE Phlo Corporation
    NEW YORK, April 10 /PRNewswire/ -- Phlo Corporation
 (OTC Bulletin Board:   PHLC) ("Phlo") announced today that it has begun shipping
 approximately 200,000 cases of Phlo's flagship ZO - Vital Cell Defense and
 McCoy's beverage products from its co-packing facility in Carteret, New Jersey
 to satisfy a current backlog of approximately $1.8 million.  This backlog
 consists of purchase orders from Phlo's major distributors such as the
 Coca-Cola Bottling Company of Chicago, Inc. (including its affiliates), Haddon
 House, and Atlantic Beverages.  Phlo plans to produce another 200,000 cases of
 its beverages at the end of April to fill orders from its distributors for the
 following 30 day period.
     "This is a pivotal time in the Company's development as we believe that
 the filling of such orders and the meeting of the demand from our existing
 distributors for the ensuing 12 months should allow the Company to be
 profitable for every quarter during the next 12 month period and to show a
 material profit for our fiscal year 2001," James B. Hovis, President and CEO
 of Phlo, said today.  "The Company's operating results for its first fiscal
 quarter of 2001 should generate a substantial balance sheet capable of
 supporting traditional asset-based lending for production financing in the
 future."
     Phlo's ZO - Vital Cell Defense beverages contain Phlo's patent-pending
 payload, Vitamin E phosphate/phosphatidylcholine, which is protected through
 the stomach (micro-encapsulated) and time-released.  This technology has been
 shown through in vitro and in vivo tests to be effective in protecting cells
 from the effects of aging and exposure to toxins.  Further, the patent-pending
 payload has been shown to be effective in stimulating the membrane repair
 function of cells, particularly of the liver, heart, and brain.
     Phlo's distributors currently sell to an account base of approximately
 100,000 accounts, encompassing territories including eastern New York, New
 Jersey, Pennsylvania, Delaware, Maryland, Virginia, North Carolina, South
 Carolina, and Florida, and reaching westward to Illinois, Indiana, Wisconsin,
 Ohio, western Pennsylvania, and western New York (including the major
 metropolitan areas of Chicago, IL, Milwaukee, WI, Indianapolis, IN, and
 Rochester, NY).
 
     Phlo is a manufacturer of beverages containing patented and patent-pending
 biotechnologies.  Phlo's ZO - Vital Cell Defense line of beverages is
 available in ten flavors including Orange Carrot, Cranberry Berry, Tropical
 Punch, Pink Lemonade, Kiwi Strawberry, Raspberry Vanilla, Blackberry Cherry,
 Lemon Iced Tea, Peach Iced Tea, and Raspberry Iced Tea.  Phlo's McCoy's Green
 Tea beverage line, available in five different flavors, is the first and only
 new age beverage that delivers a truly functional level (250 mg) of powerful
 green tea catechins, including the super anti-oxidant EGCg.  Studies show that
 a high daily intake of EGCg aids in the protection against cancer and
 cardiovascular disease.  McCoy's Green Teas also feature Vitamin C and
 Siberian ginseng for sustained energy and concentration.  Phlo is based in New
 York City at 475 Park Avenue South, Seventh Floor, New York, New York 10016.
 For more information, contact Michael J. Sclafani, Wall Street Communications
 Group, Inc., 303-541-0970, sclafani@uswest.net.
 
     Certain statements made herein constitute "forward-looking" statements
 within the meaning of the Private Litigation Reform Act of 1995.  Such
 statements are based on a number of assumptions and on information and
 estimates supplied to Phlo Corporation by its distributors.  Such assumptions
 and estimates are subject to uncertainties, contingencies, and other factors,
 many of which are beyond Phlo's control.  Actual results may differ materially
 from the statements set forth above.
 
 SOURCE  Phlo Corporation